Receiving treatment in a clinical trial should be carefully considered, and your Memorial Sloan-Kettering MDS physician will help you to decide if such a treatment is right for you. Before you enroll in a clinical trial, you may wish to consider the following:
- A number of eligibility criteria will need to be met, which relate to your disease and your general health. To determine your eligibility for a clinical trial, additional blood tests and sometimes bone marrow tests are needed. Other tests, such as an electrocardiogram, or EKG (a test of heart function), may also be performed.
- Involvement in clinical trials usually involves multiple trips to Memorial Sloan-Kettering to receive the new treatment, to undergo extra tests to learn more about the new treatment, or to monitor for side effects.
- New treatments being tested in trials have not yet been proven to be better than standard treatments such as 5-azacytidine, decitabine, and lenalidomide.
- If you have already received standard treatments, then clinical trials may be an option to consider in addition to receiving supportive care.
- Every clinical trial is different and your MDS physician can help you to determine which trial may be the best for you.
- Sometimes, clinical trials should be considered as the first treatment. Please discuss this with your MDS physician to see if this is the right choice for you.
Here you can find a continually updated listing of Memorial Sloan-Kettering’s current clinical trials for adults with myelodysplastic syndrome (MDS). To learn more about a study, choose from the list below.
